Difference between revisions of "Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5 (Q9614)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created a new Item: #quickstatements; #temporary_batch_1589975872009)
 
(‎Created claim: Fourth Author string (P152): Lee YC, #quickstatements; #temporary_batch_1590155310798)
 
(11 intermediate revisions by the same user not shown)
Property / First Author string
 +
Yu D
Property / First Author string: Yu D / rank
 +
Normal rank
Property / Second Author string
 +
Shin HS
Property / Second Author string: Shin HS / rank
 +
Normal rank
Property / Third Author string
 +
Lee YS
Property / Third Author string: Lee YS / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1038/labinvest.2014.125 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 25286029 / rank
 +
Normal rank
Property / Publication Date
 +
2014
Timestamp+2014-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2014 / rank
 +
Normal rank
Property / Published In Name String
 +
Lab. Invest.
Property / Published In Name String: Lab. Invest. / rank
 +
Normal rank
Property / Volume
 +
94
Property / Volume: 94 / rank
 +
Normal rank
Property / title
 +
miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English)
Property / title: miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English) / rank
 +
Normal rank
Property / Page(s)
 +
1370-1381
Property / Page(s): 1370-1381 / rank
 +
Normal rank
Property / Fourth Author string
 +
Lee YC
Property / Fourth Author string: Lee YC / rank
 +
Normal rank
links / sliswiki / namelinks / sliswiki / name
 +

Latest revision as of 13:49, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Yu D
    0 references
    Shin HS
    0 references
    Lee YS
    0 references
    0 references
    2014
    0 references
    Lab. Invest.
    0 references
    94
    0 references
    miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English)
    0 references
    1370-1381
    0 references
    Lee YC
    0 references